ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population

BACKGROUND: ICG-001, a small molecule, binds CREB-binding protein (CBP) to disrupt its interaction with β-catenin and inhibits CBP function as a co-activator of Wnt/β-catenin-mediated transcription. Given its ability to inhibit Wnt/β-catenin signaling pathway, ICG-001 has been used in some tumor typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Chen, Hui, Zheng, Peiming, Zheng, Yingxia, Luo, Qin, Xie, Guohua, Ma, Yanhui, Shen, Lisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594604/
https://www.ncbi.nlm.nih.gov/pubmed/28893318
http://dx.doi.org/10.1186/s13046-017-0595-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594604/
https://www.ncbi.nlm.nih.gov/pubmed/28893318
http://dx.doi.org/10.1186/s13046-017-0595-0

Ejemplares similares